Dr Sandy Hogg
SVP Alliance Management
Sandy has a PhD in Neuropharmacology and over 25 years Pharmaceutical R&D, Strategy and Business Development experience from large pharmaceutical and micro biotech startup companies alike.
She was Head of Psychopharmacology at Lundbeck, where she successfully project managed several drug candidates into the early stages of clinical development, including the antidepressant vortioxetine; the first drug to receive the labelling for cognitive enhancement in depression. Moving into BD she was involved in the partnering of Lundbeck’s depression portfolio with Takeda, and the in-licensing of a number of mid to late stage drug candidates.
Before joining PrecisionLife, Sandy co-founded a series of biotech companies within CNS drug discovery, drug discovery contract research and animal health raising significant venture and non-dilutive funding in the process. Sandy has worked in France, Denmark and the Netherlands, and is now based in the UK, close to Cambridge.